Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-01-04 @ 1:16 PM
Study NCT ID:
NCT00547066
Status:
TERMINATED
Last Update Posted:
2021-08-16
First Post:
2007-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11
Start Date Type:
None
Primary Completion Date:
2011-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-17
First Submit QC Date:
None
Study First Post Date:
2007-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-08-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-08-12
Last Update Post Date:
2021-08-16
Last Update Post Date Type:
ACTUAL